Reed's, Inc. Announces $3.4 Million Financing Transaction
Apr 24, 2017 17:00 pm UTC| Business
LOS ANGELES, April 24, 2017 -- Reed's, Inc. (NYSE MKT:REED), maker of the top selling all natural sodas in natural food and grocery stores nationwide, today announced the closing of a $3.4 million private placement in...
SelectAccount® announces new member of sales leadership team
Apr 24, 2017 16:51 pm UTC| Business
Eagan, MN, April 24, 2017 -- SelectAccount, a leader in health spending administration and one of the largest HSA non-bank custodians, announced today that Greg Champlain has joined the company as the Senior Vice...
Firm explores new client solutions with Neota Logic
Apr 24, 2017 16:32 pm UTC| Business
NEW YORK, April 24, 2017 -- International law firm Simmons Simmons has announced it is working with Neota Logic toexplore ways in which its award-winning Artificial Intelligence software platform can be used inthe...
Airbus Perlan Mission II Kicks Off Second Season Exploring Skies Above the Sierra Nevada
Apr 24, 2017 16:14 pm UTC| Business
MINDEN, Nev., April 24, 2017 -- Airbus Perlan Mission II, an initiative to fly a glider without an engine to the edge of space to collect ground-breaking insights on high-altitude flight, weather, and climate change,...
Inspirational keynote by Calif. deputy police chief to open national school safety conference
Apr 24, 2017 16:10 pm UTC| Business
Hoover, Ala., April 24, 2017 -- Long Beach, Calif., Deputy Police Chief Michael Beckman will open the July National Association of School Resource Officers’ (NASRO) school safety conference in Washington,...
Imagination shatters price barriers to SoC embedded software development
Apr 24, 2017 16:10 pm UTC| Business
LONDON, April 24, 2017 -- Imagination Technologies (IMG.L) announces availability of a powerful development environment for its MIPS M-class and I-class CPU IP cores that includes a state-of-the-art Graphical User...
Apr 24, 2017 16:05 pm UTC| Business
CAMBRIDGE, Mass., April 24, 2017 -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human...